Takeda said to have left industry trade group BIO
https://seekingalpha.com/news/4094442-takeda-leaves-industry-trade-group-bio?source=feed_sector_healthcare
Apr 25, 2024 - Takeda Pharmaceutical (TAK) joins Pfizer (PFE) in leaving the Biotechnology Innovation Organization, the top biotech lobbying group. Read more here.
0
INmune Bio provides update on Alzheimer's candidate XPro
https://seekingalpha.com/news/4096265-inmune-bio-provides-update-alzheimers-candidate-xpro?source=feed_sector_healthcare
Apr 30, 2024 - INmune Bio's experimental Alzheimer's treatment XPro shows promising results in stabilizing cognitive states of patients in compassionate use program. Read more here.
0
Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade
https://www.zacks.com/stock/news/2263665/entera-bio-ltd-entx-stock-slides-as-market-rises-facts-to-know-before-you-trade?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2263665
Apr 26, 2024 - The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close.
0
Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap
https://seekingalpha.com/news/4095540-annovis-bio-alzheimers-tumbles-53-data-alzheimers-candidate-buntanetap?source=feed_sector_healthcare
Apr 29, 2024 - Annovis Bio's Alzheimers disease candidate, buntanetap, triggers trading halts as shares fall ~53%, indicating potential disappointment in trial results. Read more here
0
Pages: 1
Page 1